(Q37147226)

English

Disease-modifying antirheumatic drug use in the treatment of juvenile idiopathic arthritis: a cross-sectional analysis of the CARRA Registry

scientific article published on August 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 August 2017

Disease-modifying antirheumatic drug use in the treatment of juvenile idiopathic arthritis: a cross-sectional analysis of the CARRA Registry (English)

1 reference

Europe PubMed Central

18 August 2017

juvenile rheumatoid arthritis

1 reference

based on heuristic

inferred from title

Timothy Beukelman

1

object named as

Timothy Beukelman

1 reference

Europe PubMed Central

18 August 2017

author name string

Sarah Ringold

2

1 reference

Europe PubMed Central

18 August 2017

Trevor E Davis

3

1 reference

Europe PubMed Central

18 August 2017

Esi Morgan DeWitt

4

1 reference

Europe PubMed Central

18 August 2017

Christina F Pelajo

5

1 reference

Europe PubMed Central

18 August 2017

Pamela F Weiss

6

1 reference

Europe PubMed Central

18 August 2017

Yukiko Kimura

7

1 reference

Europe PubMed Central

18 August 2017

CARRA Registry Investigators

8

1 reference

Europe PubMed Central

18 August 2017

language of work or name

0 references

publication date

1 August 2012

1 reference

Europe PubMed Central

18 August 2017

The Journal of Rheumatology

1 reference

Europe PubMed Central

18 August 2017

39

1 reference

Europe PubMed Central

18 August 2017

9

1 reference

Europe PubMed Central

18 August 2017

1867-1874

1 reference

Europe PubMed Central

18 August 2017

Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763075

6 September 2017

Evidence-based, interdisciplinary guidelines for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763075

6 September 2017

2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763075

6 September 2017

A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763075

6 September 2017

Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis: findings from an open-label treatment extension.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763075

6 September 2017

Disease activity and disability in children with juvenile idiopathic arthritis one year following presentation to paediatric rheumatology. Results from the Childhood Arthritis Prospective Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763075

6 September 2017

Adalimumab with or without methotrexate in juvenile rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763075

6 September 2017

Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763075

6 September 2017

Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763075

6 September 2017

Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763075

6 September 2017

Adalimumab in the therapy of uveitis in childhood

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763075

6 September 2017

ASAS/EULAR recommendations for the management of ankylosing spondylitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763075

6 September 2017

International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763075

6 September 2017

Infliximab or etanercept in the treatment of children with refractory juvenile idiopathic arthritis: an open label study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763075

27 June 2018

Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763075

27 June 2018

Duration of etanercept treatment and reasons for discontinuation in a cohort of juvenile idiopathic arthritis patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763075

3 September 2018

Early outcomes and improvement of patients with juvenile idiopathic arthritis enrolled in a Canadian multicenter inception cohort

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763075

3 September 2018

Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763075

3 September 2018

Prevalence and outcome of juvenile idiopathic arthritis-associated uveitis and relation to articular disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763075

3 September 2018

Juvenile idiopathic arthritis classification criteria: loopholes and diagnosis software.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763075

3 September 2018

Leflunomide or methotrexate for juvenile rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763075

3 September 2018

A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3763075

4 December 2018

Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor alpha monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis: results of an open-label prospective study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22859354

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines

1 reference

https://pubmed.ncbi.nlm.nih.gov/22859354

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variation in the initial treatment of knee monoarthritis in juvenile idiopathic arthritis: a survey of pediatric rheumatologists in the United States and Canada

1 reference

https://pubmed.ncbi.nlm.nih.gov/22859354

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: results of a six-month, multicenter, randomized, double-blind, controlled, phase IV trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22859354

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate

1 reference

https://pubmed.ncbi.nlm.nih.gov/22859354

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/22859354

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recommendations for juvenile idiopathic arthritis by the American College of Rheumatology: comment on the article by Beukelman et al

1 reference

https://pubmed.ncbi.nlm.nih.gov/22859354

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug survival of the first and second course of anti-tumour necrosis factor agents in juvenile idiopathic arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22859354

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register

1 reference

https://pubmed.ncbi.nlm.nih.gov/22859354

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3899/JRHEUM.120110

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37147226&oldid=1823658141"